RecruitingNot Applicable

CIED Infection Quality Initiative Demonstration Project

United States200 participantsStarted 2023-05-10

Plain-language summary

The aim of this Quality Initiative (QI) demonstration project is to develop a model to increase guideline-driven care for patients with cardiovascular implantable electronic devices (CIED) infection. Multidisciplinary teams will be established to carry out the multifaceted intervention. This program seeks to improve early identification and diagnosis, appropriate treatment, and faster time to treatment of CIED infection.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Positive blood culture (two or more positive blood cultures for typical skin organisms (coagulase-negative staphylococci, Corynebacterium species, Propionobacterium species), or one positive blood culture for all other microorganisms), with no other source identified to explain the bacteremia
✓. Cases with definite evidence of pocket infection (defined as localized erythema, swelling, pain, tenderness, warmth, erosion, or drainage), if treated with antibiotics before culture, even with negative culture, will be considered device infection

What they're measuring

Proportion of patients with CIEDs and positive blood cultures who receive extraction (per guidelines)

Timeframe: Up to 12 months

Proportion of patients with CIEDs and definite pocket infections who receive extraction (per guidelines)

Timeframe: Up to 12 months

Trial details

NCT IDNCT05471973

SponsorDuke University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-03-31

Contact for this trial

Kimberly Ward, MPH

9196606409 kimberly.t.ward@duke.edu

View on ClinicalTrials.gov More Infections trials